scispace - formally typeset
A

Abhijeet Kumar

Researcher at Central University, India

Publications -  19
Citations -  405

Abhijeet Kumar is an academic researcher from Central University, India. The author has contributed to research in topics: Catalysis & Cancer. The author has an hindex of 7, co-authored 16 publications receiving 221 citations. Previous affiliations of Abhijeet Kumar include Dr. Reddy's Laboratories & Indian Institute of Technology Kanpur.

Papers
More filters
Journal ArticleDOI

Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development.

TL;DR: Molecular docking studies using 10 potential naturally occurring compounds against the SARS-CoV-2 spike protein and compared their affinity with an FDA approved repurposed drug hydroxychloroquine revealed that these molecules bind with the hACE2-S complex with low binding free energy, and ADME analysis suggested that they consist of drug-likeness property, which may be further explored as anti-SARS- CoV- 2 agents.
Posted ContentDOI

Targeting SARS-CoV-2 Spike Protein of COVID-19 with Naturally Occurring Phytochemicals: An in Silco Study for Drug Development

TL;DR: These flavonoid and non-flavonoid moieties have significantly high binding affinity for the two main important domains of the spike protein which is responsible for the attachment and internalization of the virus in the host cell and their binding affinities are much higher compared to that of HCQ.
Journal ArticleDOI

Targeting virus-host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19.

TL;DR: Pyrimidine derivative AP-NP may be explored as an effective inhibitor for hACE2-S complex and in vitro and in vivo studies will strengthen the use of these inhibitors as suitable drug candidates against SARS-COV-2.
Journal ArticleDOI

Pd-catalyzed chemo-selective mono-arylations and bis-arylations of functionalized 4-chlorocoumarins with triarylbismuths as threefold arylating reagents

TL;DR: In this paper, cross-coupling reactions of differently substituted 4-chlorocoumarins were studied under palladium catalysis using triarylbismuths as threefold arylating reagents.
Journal ArticleDOI

Pd-catalyzed cross-coupling study of bi-functional 3-bromo-4-trifloxycoumarins with triarylbismuth reagents

TL;DR: P palladium-catalyzed reactions afforded chemo-selective C-4 arylations with the facile formation of 3-bromo-4-arylcoumarins in good to high yields.